Copyright
©2013 Baishideng Publishing Group Co.
World J Gastroenterol. Sep 7, 2013; 19(33): 5485-5492
Published online Sep 7, 2013. doi: 10.3748/wjg.v19.i33.5485
Published online Sep 7, 2013. doi: 10.3748/wjg.v19.i33.5485
Figure 6 Propofol abrogates gemcitabine-induced nuclear factor-κB in MIA-PaCa-2 cells.
A: MIA-PaCa-2 cells were exposed to 10-100 μmol/L gemcitabine for 72 h. Nuclear extracts were analyzed by electrophoretic mobility shift assay (EMSA); B: Propofol abrogated gemcitabine induced nuclear factor-κB (NF-κB) in MIA-PaCa-2 cells exposed to 100 μmol/L/mL propofol for 24 h followed by incubation with 100 μmol/L gemcitabine. Nuclear extracts were harvested at 72 h and analyzed by EMSA. Propofol pretreatment downregulated gemcitabine-induced NF-κB with 100 μmol/L gemcitabine.
-
Citation: Du QH, Xu YB, Zhang MY, Yun P, He CY. Propofol induces apoptosis and increases gemcitabine sensitivity in pancreatic cancer cells
in vitro by inhibition of nuclear factor-κB activity. World J Gastroenterol 2013; 19(33): 5485-5492 - URL: https://www.wjgnet.com/1007-9327/full/v19/i33/5485.htm
- DOI: https://dx.doi.org/10.3748/wjg.v19.i33.5485